Oruka Therapeutics, Inc. ($ORKA)
Filing Information
| Accession Number | 0000907654-26-000002 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 3, 2026 |
| Document Date | Jan 2, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
23,000
Total Value
$409,795.08
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer | Common Stock | โ | Jan 2, 2026 | Exercise/Conversion | 5,000 | $7.80 | $39,000.00 | 218,084 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Jan 2, 2026 | Sale | 8,748 | $28.17 | $246,396.17 | 209,336 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Jan 2, 2026 | Sale | 3,144 | $29.08 | $91,431.92 | 206,192 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Jan 2, 2026 | Sale | 1,108 | $29.75 | $32,966.99 | 205,084 | Direct | โ | View Details | |
Chief Operating Officer | Employee Warrant (right to buy) | Derivative | Jan 2, 2026 | Exercise/Conversion | 5,000 | $0.00 | $0.00 | 94,996 | Direct | โ | View Details |